跳至主要内容
临床试验/NCT01534559
NCT01534559已完成4 期

A Pharmacist-led Medicines Management Outpatient Service for Patients at High Risk of Medication Related Problems

Queen's University, Belfast2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
62
试验地点
2
主要终点
Time to readmission to hospital

研究概览

简要总结

It widely accepted that a number of medication related problems can occur after the patient has been discharged from the hospital. An obvious extension of the ongoing integrated medicines management programme (IMMP) is therefore to provide a medicines management clinic within an outpatient setting as well as follow-up telephone calls from a clinical pharmacist. This study aims to assess the influence a pharmacist-led medicines management outpatient service on patients at high risk of medication related problems.

It is anticipated that this service will

  • Ensure continuity of pharmaceutical care for patients post discharge.
  • Reinforce patient education in order to improve knowledge and understanding of the medication prescribed.
  • Ensure that both prescription medicines and OTC preparations are used appropriately.
  • Facilitate the communication with other members of healthcare team in order to agree and implement measures to overcome medication related problems.

详细描述

Patient safety and wellbeing are central concerns within the health service. Recent publications have highlighted the importance of medicines management and have called for local strategies to be introduced. An Integrated Medicines Management Programme (IMMP) has been implemented within Northern Health and Social Care Trust to ensure that a co-ordinated pharmacy service is available throughout the hospital stay for its medical patients. The IMMP has resulted in a number of benefits including improved patient safety, more effective use of medications, reduced length of stay, reduced readmissions rates, improved communication across the healthcare interface and user satisfaction.

It is widely accepted that a number of medication related problems can occur post discharge when complicated medication regimens can often prove confusing. This can lead to mismanagement of medicines and early rehospitalisation of patients. Although these problems are frequently commented upon, research in this area is still lacking. The present project aims to examine an extension of the present IMM service by evaluating the impact/patient benefit of a customised outpatient service provided by clinical pharmacy staff to patients post-discharge. An increase in patients' medicines adherence, a greater satisfaction with information about their medicines, improved beliefs about the necessity of their medicines, a decrease in medicines-related problems, a decrease in re-hospitalisation rates, extended time to re-hospitalisation, and a decrease in overall costs of patients care is anticipated.

This study will be carried out as a collaboration between the School of Pharmacy at Queen's University Belfast and the Northern Health and Social Care Trust (2 sites; Antrim Area Hospital and Whiteabbey Hospital).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients (>= 18 years old) admitted into one of the study hospitals as acute/unscheduled medical admission and meet at least one of the following criteria:
  • Prescribed five or more regular long term medications.
  • Have three or more changes to medications during hospital stay.
  • Past history of medication related problems.
  • Patient referred to the medicines management clinic service by hospital doctor or clinical pharmacist due to concerns about ability to manage medicines in primary care.

排除标准

  • Patient being discharged to residential/nursing homes
  • Palliative care patients
  • Patients unable to give informed consent e.g. Alzheimer's Disease
  • Patients unable to use telephone at home.

结局指标

主要结局

Time to readmission to hospital

时间窗: Over 12 month post discharge

次要结局

  • Number of GP consultations and GP home visits(over 12 month post discharge)
  • Number of Accident and Emergency (A&E) visits(over 12 month post discharge)
  • Health-related quality of life (HRQOL)(Over 12 months post discharge, every 4 months)
  • Number of Readmission(Over 12 months post discharge)
  • Cost Utility Analysis(Over 12 month post discharge.)
  • Medication Adherence Assessments;(Over 12 month post discharge. Every 4 months.)
  • Medication Appropriateness Index (MAI) score(Will be assessed at dischrge and 4, 8 and 12 month post discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James McElnay

Chief Investigator

Queen's University, Belfast

研究点 (2)

Loading locations...

相似试验